CCDR: Volume 46-5 -May 2020: Nosocomial infection surveillance
The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.
- Publisher
- Public Health Agency of Canada
- Resources
- 44
- Catalogue metadata updated
- 2020-06-01
Data overview
- Formats
- HTML, PDF
- File languages
- English, French
Official sources and licences
Resources
- Canadian Public Health Laboratory Network Best Practices for COVID-19 (English, HTML) HTML
- Canadian Public Health Laboratory Network Best Practices for COVID-19 (English, PDF) PDF
- Canadian Public Health Laboratory Network Best Practices for COVID-19 (French, HTML) HTML
- Canadian Public Health Laboratory Network Best Practices for COVID-19 (French, PDF) PDF
- Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19 (French, PDF) PDF
- Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19 (English, PDF) PDF
- Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19 (French, HTML) HTML
- Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19 (English, HTML) HTML
- CCDR: Volume 46-5 -May 2020: Nosocomial infection surveillance (English, PDF) PDF
- CCDR: Volume 46-5 -May 2020: Nosocomial infection surveillance (French, HTML) HTML
- CCDR: Volume 46-5 -May 2020: Nosocomial infection surveillance (French, PDF) PDF
- CCDR: Volume 46-5 -May 2020: Nosocomial infection surveillance (English, HTML) HTML
- Determinants of HIV and hepatitis C among people who inject drugs in Canada, 2017–2019 (English, HTML) HTML
- Determinants of HIV and hepatitis C among people who inject drugs in Canada, 2017–2019 (English, PDF) PDF
- Determinants of HIV and hepatitis C among people who inject drugs in Canada, 2017–2019 (French, HTML) HTML
- Determinants of HIV and hepatitis C among people who inject drugs in Canada, 2017–2019 (French, PDF) PDF
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014–2018 (English, PDF) PDF
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014–2018 (French, PDF) PDF
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014–2018 (French, HTML) HTML
- Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014–2018 (English, HTML) HTML
- Laboratory-confirmed COVID-19 in children and youth in Canada, January 15–April 27, 2020 (French, HTML) HTML
- Laboratory-confirmed COVID-19 in children and youth in Canada, January 15–April 27, 2020 (French, PDF) PDF
- Laboratory-confirmed COVID-19 in children and youth in Canada, January 15–April 27, 2020 (English, PDF) PDF
- Laboratory-confirmed COVID-19 in children and youth in Canada, January 15–April 27, 2020 (English, HTML) HTML
- Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context (English, HTML) HTML
- Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context (French, HTML) HTML
- Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context (French, PDF) PDF
- Modified two-tiered testing algorithm for Lyme disease serology: the Canadian context (English, PDF) PDF
- National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017–2019 (English, HTML) HTML
- National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017–2019 (French, HTML) HTML
- National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017–2019 (English, PDF) PDF
- National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017–2019 (French, PDF) PDF
- Summary of the NACI Seasonal Influenza Vaccine Statement for 2020–2021 (French, HTML) HTML
- Summary of the NACI Seasonal Influenza Vaccine Statement for 2020–2021 (English, PDF) PDF
- Summary of the NACI Seasonal Influenza Vaccine Statement for 2020–2021 (French, PDF) PDF
- Summary of the NACI Seasonal Influenza Vaccine Statement for 2020–2021 (English, HTML) HTML
- Surveillance of persons who tested negative for COVID-19 in Ontario, January 22–February 22, 2020 (French, PDF) PDF
- Surveillance of persons who tested negative for COVID-19 in Ontario, January 22–February 22, 2020 (English, PDF) PDF
- Surveillance of persons who tested negative for COVID-19 in Ontario, January 22–February 22, 2020 (French, HTML) HTML
- Surveillance of persons who tested negative for COVID-19 in Ontario, January 22–February 22, 2020 (English, HTML) HTML
- Vaccine acceptance: How to build and maintain trust in immunization (French, HTML) HTML
- Vaccine acceptance: How to build and maintain trust in immunization (English, PDF) PDF
- Vaccine acceptance: How to build and maintain trust in immunization (English, HTML) HTML
- Vaccine acceptance: How to build and maintain trust in immunization (French, PDF) PDF